Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Other financing activities (2018 - 2022)

OptimizeRx's Other financing activities history spans 9 years, with the latest figure at $4.3 million for Q3 2022.

  • On a quarterly basis, Other financing activities rose 324.33% to $4.3 million in Q3 2022 year-over-year; TTM through Sep 2022 was $12.5 million, a 317.05% increase, with the full-year FY2018 number at $1.9 million, changed N/A from a year prior.
  • Other financing activities hit $4.3 million in Q3 2022 for OptimizeRx, up from $4.0 million in the prior quarter.
  • Over the last five years, Other financing activities for OPRX hit a ceiling of $4.3 million in Q3 2022 and a floor of $408087.0 in Q2 2019.
  • Historically, Other financing activities has averaged $1.4 million across 5 years, with a median of $754512.0 in 2020.
  • Biggest five-year swings in Other financing activities: decreased 22.84% in 2021 and later skyrocketed 445.23% in 2022.
  • Tracing OPRX's Other financing activities over 5 years: stood at $1.0 million in 2018, then plummeted by 54.34% to $469539.0 in 2019, then surged by 34.48% to $631453.0 in 2020, then skyrocketed by 59.63% to $1.0 million in 2021, then skyrocketed by 324.33% to $4.3 million in 2022.
  • Business Quant data shows Other financing activities for OPRX at $4.3 million in Q3 2022, $4.0 million in Q2 2022, and $3.2 million in Q1 2022.